# Evaluation of Histological Criteria and Immunoserological Testing of Simplified Criteria for the Diagnosis of Autoimmune Hepatitis

**Authors:** Kenan Moral, Cumali Efe, Ayşenur Sert, Berkay Şimşek, Dilara Turan Gökçe, Nergiz Ekmen, Ersin Batıbay, Murat Kekilli, Tarkan Karakan, Mehmet Ibiş, Güner Kiliç, Ersan Ozaslan, Haluk Cihad Albayrak, Veysel Baran Tomar, Derya Arı, Dilek Yapar, Meral Akdoğan, Mehmet Cindoruk, Staffan Wahlin, Guldal Esendagli, Nesrin Turhan, Gulen Akyol

PMC · DOI: 10.5152/tjg.2025.25402 · The Turkish Journal of Gastroenterology · 2025-09-18

## TL;DR

This study evaluates new criteria for diagnosing autoimmune hepatitis, finding that updated methods improve accuracy compared to older standards.

## Contribution

The study validates the improved diagnostic performance of updated histological and simplified criteria for autoimmune hepatitis.

## Key findings

- The 2022 histological criteria showed higher sensitivity and specificity than the 2008 criteria for diagnosing autoimmune hepatitis.
- The updated simplified criteria improved diagnostic accuracy with better specificity and a higher area under the curve.
- The new diagnostic algorithm is recommended to replace older methods for more accurate autoimmune hepatitis diagnosis.

## Abstract

The International Autoimmune Hepatitis (AIH) Group recommends the new histological criteria (HC) (2022) and modified immunoserological testing for diagnosing AIH. The diagnostic utility of the 2022 HC was evaluated. The simplified criteria were also updated with the 2022 HC and immunoserological testing and assessed the diagnostic performance.

The data of 207 patients (111 AIH, 33 primary biliary cholangitis, 35 drug-induced liver injury, and 28 metabolic dysfunction–associated fatty liver disease) were evaluated.

The 2022 HC and the 2008 simplified HC showed 95% vs. 88% sensitivity and 82% vs. 49% specificity for possible/compatible AIH. For likely/typical AIH, sensitivity was 60% vs. 42% and specificity was 98% vs. 95% for the 2022 HC and the 2008 HC, respectively. The area under the curve (AUC) was better for the 2022 HC than for the 2008 simplified HC (0.932 vs. 0.771, P < .001). The updated simplified criteria had a sensitivity comparable with the simplified criteria (88% vs. 87%) but a better specificity (94% vs. 80%) for probable AIH. The sensitivity was slightly lower (57% vs. 63%), but the specificity was greater (97% vs. 89%) for definitive AIH. The AUC was higher in the updated simplified criteria than in the simplified criteria (0.959 vs. 0.894, P = .016).

The 2022 HC showed better sensitivity and specificity than the 2008 simplified HC for AIH. The updated simplified criteria worked well with improved accuracy of AIH diagnosis. Our results suggest that the diagnostic algorithm of AIH should be modified based on recent recommendations.

## Linked entities

- **Diseases:** Autoimmune Hepatitis (MONDO:0016264), primary biliary cholangitis (MONDO:0005388), drug-induced liver injury (MONDO:0005359)

## Full-text entities

- **Diseases:** AIH (MESH:D019693), fatty liver disease (MESH:D005234), metabolic dysfunction (MESH:D008659), liver injury (MESH:D017093), primary biliary cholangitis (MESH:D008105)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12910304/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12910304/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12910304/full.md

---
Source: https://tomesphere.com/paper/PMC12910304